Exploring Therapeutic Problems in Women with Multiple Sclerosis: A Qualitative Study

Khftan, Parvaneh; Vameghi, Roshanak; Khankeh, Hamid Reza; Fathi, Mansour; Arshi, Maliha; Gholami Jam, Fatemeh

Exploring Therapeutic Problems in Women with Multiple Sclerosis: A Qualitative Study

Authors

parvaneh khftan

Roshanak Vameghi

Hamid Reza Khankeh

Mansour fathi

Maliha arshi

Fatemeh Gholami Jam

Abstract

Introduction: Multiple sclerosis (MS) is one of the most important diseases of the nervous system. The incidence of this disease in women is about two to three times that of men. The main cause of this disease is not fully understood and there is no definitive treatment for it. The aim of this study was to identify the treatment problems in this group of patients.
Method: In this qualitative study, content analysis method was used. Based on the purposive sampling method and theoretical saturation criterion, 23 patients with multiple sclerosis who referred to the Association for the Protection of Menthol Patients in Tehran, Iran, during the year 2014 participated in this study. Semi-structured interview method was used to collect the data. Data were analyzed using qualitative content analysis method.
Results: Out of the interviews, 1100 codes were obtained in three stages of analysis. These codes fell into one category of treatment problems and five subcategories of "high cost of treatment", "lack of access to medicine", "neglecting patient's rights from doctors and medical personnel", "lack of adequate empathy from medical personnel", and "Complications of medications".
Conclusion: Patients with multiple sclerosis are facing specific problems in the treatment of their illness, which require social attention and protection; they can be supported by appropriate insurance coverage and the provision of medicines, especially foreign drugs, at affordable and low-cost tariffs by the government and the community. A great contribution is needed to reduce the pain and suffering of this group of patients.

Keywords

qualitative research

therapy

Multiple Sclerosis

1. Nolte E, McKee M. Caring for people with chronic conditions: a health system perspective, European Observatory on Health Systems and Policies series. New York: Open University Press; 2008. 2. Abedini M, Habibi Saravi R, Zervani A, Farahmand M. Epidemiology of Multiple sclerosis in Mazandaran. J Mazandaran Univ Med Sci. 2007; 18 (66): 82-7. (Persian) 3. Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clinical Psychology Review.2009;29(2):141-153. 4. Flesner G Christina A et al. Lived experienced of MS-related fatigue: A phenomenological interview study, International Journal of Nursing Studies 2003; 40(7): 707-717. 5. Hughes M . Multiple sclerosis and pregnancy, Neurologist Clinics 2004; 22(4) 757- 769. 6. Howarth A L. Will aromatherapy be a useful treatment strategy for people with multiple sclerosis whoexperience pain?. Complement Ther Nurs Midwifery. 2002; 8(3): 138-141. 7. Miltenburger C , Kobelt G. Quality of life and cost of multiple sclerosis. clinical Neurology and Neurosurgery 2002; 104(3) 272-275. 8. Goodin DS, Frohman EM, Garmany GP, Jr., Halper J, Likosky WH, Lublin FD, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002 Jan 22;58(2):169-78. 9. Elo S, Kyngas H. The qualitative content analysis process J of Adv Nurs.2008; 62: 107–115. 10. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today.2004; 24: 105–112. 11. Lawrence M, Samkoff MD. Multiple sclerosis : update on treatment. Hospitalcphysi. 2002;23:21-27. 12. Taylor B, McDonald E. The cost of multiple sclerosis in Australia. Journal of Neuroscience 2007; 14 (3): 532-539. 13. Rotstein Z, Hazan R, Barak Y , Achiron A. Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis. Autoimmunity Reviews 2006;5(8): 511-516 14. Morgante L. Hope in multiple sclerosis: a nursing perspective. Int J Ms Care 2000; 2(2): 9-15 15. Kenner M, Menon U, Elliott DG. Multiple sclerosis as a painful disease. Int Rev Neurobiol 2007;79:303–21. 16. Ghanati, L. 2011. Evaluation of economic costs and economic feasibility of providing insurance M.S drugs for treatment of a medical condition; Journal of Health Management 2011:14(45). [persian]. 17. parsapoor AR, Salari P, Larijani B. Implementation of Patient’s Rights Charter: a Report from Ministry ofHealth and Medical Education, Iran, Iranian J Pub Health 2013; 42(1): 9-12. 18. Rangraz Jeddi F, Rabiee R. Observance rate of patients' bill of rights in kashan hospitals in 2002. Behbood2005; 9(1): 62-71 19. Turner J, Kelly B. Emotional dimensions of chronic disease. West J Med 2000;172(2):124–8.